Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 14, 2026
Why Is HeartFlow (HTFL) Stock Up +26.8% Today?

Why Is HeartFlow (HTFL) Stock Up +26.8% Today?

Key Takeaways

  • HeartFlow shares surged approximately 26.8% in early trading Thursday, changing hands around $39.32 versus Wednesday’s close of $31.01.
  • The move was an earnings-driven rally after second-quarter results beat expectations and the company raised its full-year outlook.
  • Plaque Analysis was the standout growth driver, with revenue of $7.8 million coming in about $4 million above internal expectations.
  • Analysts raised price targets following the report, reinforcing bullish sentiment.
  • The stock was trading within roughly 5% of its 52-week high of $41.22.
  • Traders are watching Plaque adoption, second-half execution, and upcoming clinical data readouts.

Opening Summary

HeartFlow, Inc. (HTFL) is a medical technology company that provides AI-powered, non-invasive solutions for diagnosing and managing coronary artery disease. Its shares rallied sharply in early trading Thursday, rising $8.31, or about 26.8%, to $39.32, compared with a prior closing price of $31.01 on Wednesday. The move extended a strong pre-market surge and reflected an enthusiastic market reaction to second-quarter 2026 results released after Wednesday’s close, which beat revenue expectations and included raised full-year guidance.

Q2 Earnings Beat and Raised Full-Year Outlook

HeartFlow (HTFL) reported second-quarter revenue of $64.1 million, up 48% year over year and above the consensus estimate of about $56.6 million. U.S. revenue rose 51% to $59.6 million, while international and other revenue reached $4.5 million. The company’s non-GAAP net loss narrowed to $5.8 million, or $0.07 per share, from $17.6 million, or $2.79 per share, in the same period a year earlier.

Management also raised its full-year 2026 revenue guidance to a range of $246 million to $250 million, implying growth of 40% to 42%, up from a prior outlook of $228 million to $232 million. The company increased its full-year non-GAAP gross margin guidance to approximately 82% and reiterated its target of reaching cash flow profitability by mid-2028.

Plaque Momentum and Margin Expansion

A key driver of the quarter was HeartFlow’s Plaque Analysis business. Plaque revenue of $7.8 million represented about 12% of total revenue and came in roughly $4 million above the company’s expectations. Management said new account activations were ahead of plan and that coverage had reached about 78% of insured lives. The company raised its full-year Plaque revenue outlook to $29 million to $31 million and now expects approximately 1,250 activated Plaque accounts by year-end.

The core FFRCT business also contributed, with U.S. FFRCT revenue growing about 32% during the quarter. Gross margin expanded to 83.3%, up 770 basis points from 75.6% a year earlier, supported by volume leverage, AI-driven efficiencies, and a higher mix of high-margin Plaque revenue.

Analyst Price-Target Increases Reinforce the Move

The earnings-driven stock move was amplified by a wave of analyst activity. Stifel raised its price target on HTFL to $45 from $40 and maintained a Buy rating, citing strength in both the Plaque and FFRCT businesses. J.P. Morgan maintained a Buy rating with a $45 price target, while Wells Fargo maintained a Buy rating with a $39 target. The analyst response reinforced the view that HeartFlow’s accelerating revenue growth and improving margins are gaining credibility on Wall Street.

Market Context and Trading Activity

The rally appeared to be company-specific rather than driven by broad market or sector action. Shares jumped more than 20% in pre-market trading and extended those gains after the opening bell, moving from Wednesday’s close of $31.01 to around $39.32 by mid-morning Thursday. Wednesday’s regular-session volume of roughly 1.07 million shares was more than double the prior nine-session average of about 425,000 shares, indicating elevated investor interest even before the earnings announcement. The stock also traded near the upper end of its 52-week range, approaching its 52-week high of $41.22.

What Comes Next for HTFL

Investors will now focus on whether HTFL can sustain its Plaque adoption momentum and deliver on its raised revenue and margin guidance through the second half of 2026. Key catalysts include continued account activations, reimbursement developments, the DECIDE one-year outcomes expected in the fourth quarter, and broader evidence supporting expansion into the asymptomatic patient market. Risks include an ongoing competitive and regulatory environment, persistent GAAP losses, and a premium valuation that leaves the shares sensitive to any execution shortfall.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in the curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing traders to explore automated approaches matched to different market environments. Readers interested in AI-driven market analysis can visit the page to review the latest top-performing strategies.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HTFL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


HTFL sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for HTFL moved above the 200-day moving average on August 14, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

HTFL moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HTFL crossed bullishly above the 50-day moving average on August 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HTFL advanced for three days, in of 70 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 41 cases where HTFL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 12 cases where HTFL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HTFL as a result. In of 23 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HTFL turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HTFL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HTFL broke above its upper Bollinger Band on August 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HTFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.198) is normal, around the industry mean (7.359). HTFL has a moderately low P/E Ratio (0.000) as compared to the industry average of (45.681). HTFL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.515). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. HTFL's P/S Ratio (20.000) is slightly higher than the industry average of (6.056).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HTFL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.87B. The market cap for tickers in the group ranges from 708 to 44.54B. VEEV holds the highest valuation in this group at 44.54B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 0%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 19%. DH experienced the highest price growth at 31%, while CCLD experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was -56% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 74
Price Growth Rating: 53
SMR Rating: 86
Profit Risk Rating: 98
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
HTFL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Details
Interact to see
Advertisement
GE Aerospace is a focused aviation and defense company with two major segments—commercial engines and services, and defense and propulsion—earning most of its profits from long‑duration engine service on an installed base near 80,000 engines. Revenue and earnings growth have been strong, with recent quarterly revenue above 11 billion dollars, up high‑teens year over year, and net income over 2 billion dollars; management guides to 2026 EPS of 7.10–7.40 dollars, well above this year’s roughly 5.4‑dollar consensus.
Shares of Citigroup (C) declined approximately 5.17% in the most recent completed trading session, closing at $110.19 versus a prior close of $116.19. The primary catalyst was hotter-than-expected U.S. Producer Price Index (PPI) data, stoking fears of persistent inflation and a reduced likelihood of near-term Federal Reserve rate cuts.
AVAV surged +16.83% in Monday's session, trading at $294.70 compared to Friday's closing price of $252.25 — a gain of $42.45 per share. The primary catalyst was a powerful confluence of geopolitical demand and corporate developments: the escalating U.S.-Iran military conflict dramatically amplified investor focus on AeroVironment's loitering munitions portfolio.
Shares of Venture Global surged approximately +16.61% on March 2, 2026, closing at $11.30 compared to the prior close of $9.69. The primary catalyst was a stronger-than-expected Q4 2025 earnings report, with GAAP EPS of $0.41 beating the consensus estimate of $0.36 by $0.05.
Shares of CCL plunged 10.11% in Monday's session, falling from a prior close of $31.55 to $28.36. The primary catalyst was a coordinated U.S. and Israeli military strike on Iran over the weekend, causing crude oil prices to surge approximately 8–9% and triggering a global risk-off selloff.
ADT shares dropped sharply — falling as much as 13.4% intraday and hitting a new 52-week low of $6.65 — after reporting Q4 2025 results before the Monday open. Fourth-quarter revenue and guidance both missed analyst expectations, overshadowing an earnings-per-share beat.
Shares of Karman Holdings surged approximately +13.00% in Monday's session, closing near $99.57, up from a prior close of $88.11. The primary catalyst was the release of the company's fourth-quarter and full-year 2025 financial results, which showed strong revenue growth and exceeded top-line expectations.
Netflix dropped out of a months‑long bidding war for Warner Bros Discovery after Paramount/Skydance raised their offer, and Netflix refused to match it, saying the new price was “no longer financially appealing.” The stock jumped roughly 10%+ on the news as investors read this as fiscal discipline—management chose not to overpay, which protects the balance sheet and future returns instead of chasing scale at any price.
SE shares plunged approximately 23% at Tuesday's open, marking one of the steepest single-session selloffs in recent company history. The primary catalyst was a severe Q4 2025 earnings miss: adjusted EPS of $0.63 fell well short of the analyst consensus of $0.80, a miss of roughly 21%.
Shares of Southern Copper Corporation (SCCO) are down 10.32% in Tuesday's session, trading at $196.27 versus the prior close of $218.85 — a single-day loss of $22.58 per share. The primary catalyst is a Bank of America downgrade issued on March 2, cutting SCCO from Neutral to Underperform, which triggered accelerating sell pressure into Tuesday's open.
MDB shares plummeted approximately 26.44% on March 3, 2026, closing around $238.24, down from a prior close of approximately $322.55. The primary catalyst was weaker-than-expected fiscal Q1 2027 guidance, with non-GAAP EPS projected at $1.15–$1.19 versus analyst expectations of roughly $1.46.
Shares of Battalion Oil Corporation (BATL) are surging approximately +130% in Tuesday's session, with the stock hitting a fresh 52-week high as of intraday trading on March 3, 2026. The dominant catalyst is a sharp escalation of U.S.-Israel-Iran military tensions, with Tehran restricting access to the Strait of Hormuz — triggering a spike in crude oil futures and a broad-based energy sector rally.
Shares of CRDO dropped 18.55% on March 3, 2026, falling from a prior close of $114.22 to approximately $93.03. The primary catalyst was a "sell the news" reaction to fiscal Q3 2026 earnings — despite beating consensus estimates on both revenue and EPS, the market sold off on forward margin compression guidance.
PSIX shares plummeted approximately 25.37% on March 3, 2026, closing near $64.00 versus the prior session's close of $85.75. The primary catalyst was the company's Q4 and full-year 2025 earnings report, which revealed Q4 net income fell 31% year-over-year to $16.1 million despite a 33% revenue increase.
Life360 Inc Common (LIF) stunned many traders today as the stock slid more than 20% despite reporting what, on the surface, looked like very strong results: revenue up roughly 32% year over year to about $489.5 million and the company’s first-ever full‑year profitability.
StoneCo Ltd. (STNE) shares dropped more than 15% today after the market reacted negatively to the company’s latest Q4 2025 and full‑year results and its updated outlook. While StoneCo delivered year‑over‑year revenue and earnings growth and even topped EPS expectations, investors focused on weaker‑than‑hoped revenue numbers, rising credit risk metrics, and a more cautious medium‑term guidance profile, which together triggered a sharp rerating of the stock.
Alamo Group reported Q4 2025 EPS of about 1.70 dollars, well below analyst expectations that were in the low‑2 dollar range, producing a sizable negative earnings surprise. Quarterly revenue came in around 373.7 million dollars, down roughly 3% year over year and about 7–8% below consensus estimates near 405 million dollars, signaling softer demand than the market anticipated.
Hycroft Mining Holding Corp (HYMC) shares slid more than 12% today as traders digested the company’s newly filed 2025 annual report, a major corporate update, and an extended development timeline that shifts the story further away from near‑term production and cash flow.
PicS (PICS) shares dropped more than 12% today as investors reacted to mounting concerns about valuation, elevated volatility, and uncertainty ahead of the company’s next earnings report later in March.
Shares of MOBX surged approximately +532.77% in the March 3, 2026 trading session, closing at $1.12 versus a prior close of $0.18. The primary catalyst was a major production purchase order from the U.S. Navy for components used in the Tomahawk cruise missile program.